Evidence map›Paper›PMID 36497276›Full record

ArticleCancers2022

Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration.

Philippa K Brosch, Tessa Korsa, Danush Taban, Patrick Eiring, Philipp Kreisz, Sascha Hildebrand, Julia Neubauer, Heiko Zimmermann, Markus Sauer, Ryo Shirakashi and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Philippa K BroschDepartment of Biotechnology & Biophysics, Biocenter, University of Würzburg, 97074 Würzburg, Germany.
Tessa KorsaDepartment of Biotechnology & Biophysics, Biocenter, University of Würzburg, 97074 Würzburg, Germany.
Danush TabanDepartment of Biotechnology & Biophysics, Biocenter, University of Würzburg, 97074 Würzburg, Germany.
Patrick EiringDepartment of Biotechnology & Biophysics, Biocenter, University of Würzburg, 97074 Würzburg, Germany.
Philipp KreiszJulius-von-Sachs Institute, University of Würzburg, 97082 Würzburg, Germany
Sascha HildebrandDepartment of Biotechnology & Biophysics, Biocenter, University of Würzburg, 97074 Würzburg, Germany.
Julia NeubauerFraunhofer Institute for Biomedical Engineering (IBMT), 66280 Sulzbach, Germany.
Heiko ZimmermannFraunhofer Institute for Biomedical Engineering (IBMT), 66280 Sulzbach, Germany.
Markus SauerDepartment of Biotechnology & Biophysics, Biocenter, University of Würzburg, 97074 Würzburg, Germany.ORCID 0000-0002-1692-3219
Ryo ShirakashiInstitute of Industrial Science, The University of Tokyo, Tokyo 153-8505, Japan.
Cholpon S DjuzenovaDepartment of Radiation Oncology, University Hospital of Würzburg, 97080 Würzburg, Germany.
Dmitri SisarioDepartment of Biotechnology & Biophysics, Biocenter, University of Würzburg, 97074 Würzburg, Germany.
Vladimir L SukhorukovDepartment of Biotechnology & Biophysics, Biocenter, University of Würzburg, 97074 Würzburg, Germany.
University of Würzburg · DEFraunhofer Institute for Biomedical Engineering · DEThe University of Tokyo · JPUniversidad Católica del Norte · CLUniversitätsklinikum Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: The recurrence of glioblastoma multiforme (GBM) is mainly due to invasion of the surrounding brain tissue, where organic solutes, including glucose and inositol, are abundant. Invasive cell migration has been linked to the aberrant expression of transmembrane solute-linked carriers (SLC). Here, we explore the role of glucose (SLC5A1) and inositol transporters (SLC5A3) in GBM cell migration. (2) Methods: Using immunofluorescence microscopy, we visualized the subcellular localization of SLC5A1 and SLC5A3 in two highly motile human GBM cell lines. We also employed wound-healing assays to examine the effect of SLC inhibition on GBM cell migration and examined the chemotactic potential of inositol. (3) Results: While GBM cell migration was significantly increased by extracellular inositol and glucose, it was strongly impaired by SLC transporter inhibition. In the GBM cell monolayers, both SLCs were exclusively detected in the migrating cells at the monolayer edge. In single GBM cells, both transporters were primarily localized at the leading edge of the lamellipodium. Interestingly, in GBM cells migrating via blebbing, SLC5A1 and SLC5A3 were predominantly detected in nascent and mature blebs, respectively. (4) Conclusion: We provide several lines of evidence for the involvement of SLC5A1 and SLC5A3 in GBM cell migration, thereby complementing the migration-associated transportome. Our findings suggest that SLC inhibition is a promising approach to GBM treatment.

Indexed as

phlorizintransportomevolume regulation

Identifiers

PMID36497276
PMCPMC9738886
OpenAlexW4310024781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.